Induced human neurons treated with ApoE4, a prevalent ApoE variant associated with Alzheimer’s disease, also show upregulation of DLK, which leads to enhanced transcription of APP and thus Aβ levels (Huang et al., 2017). The gene discussed is MAP3K12; the disease is early-onset autosomal dominant Alzheimer disease.